保护细胞能量:线粒体营养与健康长寿

Protecting Our Cellular Energy: Mitochondrial Nutrition for Healthy Longevity

Prepared for My Upcoming ECIM (European Conogress of Integrative Medicine) Presentation

I prepared this review as part of my upcoming presentation at the 18th European Congress for Integrative Medicine (ECIM), December 3–6, 2026, in Antalya, Türkiye (conference website). It brings an I-OM Systems Medicine perspective to mitochondrial health and healthy longevity: reducing avoidable environmental and treatment-related injury while addressing individual nutrient needs, including the potential role of therapeutic doses beyond those required simply to prevent deficiency.

The full review, Mitochondrial Nutrients and Toxicants in Healthy Longevity—An Evidence Informed Framework for Environmental and Therapeutic Exposures and Contextual Orthomolecular Nutrition, is available at:
https://www.preprints.org/manuscript/202611.1180

Reduce avoidable injury. Address nutrient needs. Measure what improves.

By Richard Z. Cheng, MD, PhD
I-OM.ai — Integrative Orthomolecular Systems Medicine

Why can someone consume enough calories yet struggle with energy, muscle strength, and recovery?

Part of the answer may lie in how the body converts food into usable energy.

Mitochondria—the energy-producing structures inside our cells—help power the heart, brain, muscles, and other organs. They also participate in cellular repair, stress responses, and metabolic regulation. Their performance depends on more than fuel: they need functioning machinery, essential nutrients, and protection from damaging exposures.

My recent review, Mitochondrial Nutrients and Toxicants in Healthy Longevity, brings these issues together.[1] Its central message is straightforward:

Healthy longevity requires attention to both what may impair cellular energy production and what the body needs to sustain it.

The review is a preprint and has not undergone external peer review. It presents established biology, selected clinical studies, and an I-OM research framework—not a proven anti-aging treatment package.

Healthy longevity begins with everyday function

Longevity discussions often focus on lifespan. For most people, an equally important goal is maintaining the ability to walk, think clearly, exercise, recover from illness, and live independently.

Mitochondrial function is relevant to these goals. Lower muscle mitochondrial energetics has been associated with greater frailty in older adults. Exercise studies also show that mitochondrial function remains responsive to training, including later in life.[2,3]

These findings support protecting cellular energy capacity. They do not establish that a supplement that changes a mitochondrial laboratory marker will extend human life.

The meaningful question is: Does an intervention help people function better, with acceptable risk?

Calories alone cannot run the machinery

Food supplies energy, but vitamins and minerals help make that energy usable.

Thiamine, or vitamin B1, supports enzymes that connect fuel breakdown to energy production. Riboflavin, or B2, supplies cofactors involved in electron transfer. Niacin, or B3, supplies precursors for NAD, a molecule essential to energy metabolism.

Magnesium supports ATP-related reactions. Vitamin B12 participates in a mitochondrial metabolic pathway. Iron and copper help build the machinery of oxygen transport and cellular respiration. Vitamin C supports carnitine synthesis and other enzyme systems, while selenium contributes to antioxidant defenses.

This explains why a person can have adequate—or excessive—calorie intake while still having nutritional constraints.

It also explains why nutritional assessment deserves a place in discussions of fatigue, weakness, and recovery. These symptoms have many possible causes, however, and should not automatically be labeled “mitochondrial dysfunction.”

First, reduce avoidable injury

A supplement-centered approach can overlook continuing sources of harm.

Tobacco smoke, certain occupational pesticide exposures, toxic metals, and particulate air pollution have been linked to mitochondrial changes through experimental or human research. The strength and meaning of the evidence vary by exposure.

The practical response begins with a credible exposure history: smoking, workplace conditions, contaminated water, or a specific incident. Exposure reduction and appropriate testing can then address a plausible problem.

Nonspecific fatigue alone does not establish heavy-metal poisoning. Chelation requires a defined clinical rationale and medical supervision; it is not a routine mitochondrial supplement.

Sleep and physical activity also belong in this assessment. Experimental sleep restriction can impair muscle mitochondrial respiration, while exercise can improve it.[3] Nutritional support works within this wider physiological setting.

Mitochondrial care includes cleaner exposures, restorative sleep, suitable activity, and adequate nutrition.

Medicines deserve a thoughtful review

The preprint examines mitochondrial findings across 14 therapeutic groups, including statins, antibiotics, corticosteroids, selected psychiatric medicines, anesthetic agents, and cancer treatments.

These findings require careful interpretation. A laboratory effect, a measurable change in human tissue, and clinically important organ injury are different kinds of evidence.

For example, a small study of eight adults taking atorvastatin 80 mg daily found reduced muscle mitochondrial respiratory capacity. Participants did not report muscle pain, and the group did not show a significant change in maximal aerobic capacity.[4] The finding warrants investigation; it does not establish that all statins cause disabling mitochondrial injury.

Other medication-related problems are more immediately actionable. Long-term metformin treatment can increase the risk of vitamin B12 deficiency.[5] A person taking metformin who develops neuropathy deserves assessment for B12 deficiency and other causes.

The appropriate response is a medication review with the prescriber: Is the treatment still indicated? Is the dose appropriate? Are interactions, nutrient depletion, or adverse effects contributing to symptoms?

Necessary treatment can offer substantial benefit. Mitochondrial findings should improve prescribing and monitoring.

Beyond deficiency: the orthomolecular question

Preventing a classic deficiency disease and improving function under a specific metabolic constraint are different objectives.

Orthomolecular medicine asks whether the right nutrient, in the right form and dose, can improve a defined biological problem. In selected disorders, therapeutic nutrient doses substantially exceed ordinary dietary requirements.

The I-OM functional-dose hypothesis extends this question: might some people with impaired absorption, transport, nutrient utilization, or increased demand benefit from greater nutrient availability?

There is biological and clinical precedent. There is also considerable uncertainty about which patients respond and which doses offer the best balance of benefit and harm.

Selected examples illustrate the opportunity:

Intervention What research has reported What remains uncertain
Thiamine, B1 A trial using 600–1,800 mg/day reduced fatigue in adults with quiescent inflammatory bowel disease.[6] Whether the benefit was mitochondrial, and whether lower therapeutic doses would work as well.
Niacin, B3 A small mitochondrial-myopathy study using 750–1,000 mg/day reported restored NAD availability and improved muscle-related outcomes.[7] Whether similar benefits occur in ordinary aging or other conditions.
Vitamin D Treating severe deficiency was associated with improved muscle mitochondrial oxidative function in a small study.[8] Whether raising levels further provides additional benefit.
Coenzyme Q10 An adjunctive heart-failure trial reported improved clinical outcomes.[9] Its value for healthy adults seeking longevity benefits.
Glycine plus NAC A small older-adult trial reported improvements in glutathione-related measures, mitochondrial outcomes, and physical function.[10] Whether larger independent studies will confirm sustained benefit and safety.

These doses describe research, not a combined self-treatment regimen.

The evidence supports investigating higher-dose nutrition seriously. It also supports testing dose, formulation, patient selection, and clinical outcomes rather than assuming that more must work better.

Vitamin C: distinguish biology, clinical practice, and proof

Vitamin C is especially relevant to orthomolecular medicine because of its enzyme-supporting and redox functions.

Its route of administration matters. Oral vitamin C and intravenous vitamin C produce substantially different blood concentrations and cannot be treated as interchangeable interventions.[11]

The preprint records my practice perspective of divided oral doses of 10–15 grams daily in selected contexts. It identifies this separately from established trial evidence. That practice range is not a validated mitochondrial prescription for the general public.

The research opportunity is to determine who benefits, how much is needed, and whether improvements extend beyond blood measurements to strength, recovery, or other meaningful outcomes. Gastrointestinal tolerance, kidney disease, stone history, and route-specific risks require consideration.

Nutrients require the same seriousness as other treatments

“Nutrient” does not mean “harmless at every dose.”

Excess vitamin B6 can cause neuropathy. Prolonged high zinc intake can produce copper deficiency. Excess selenium can cause adverse effects. Magnesium can accumulate when kidney clearance is impaired. High-dose niacin requires attention to formulation, liver function, and metabolic effects.

Vitamin D also illustrates why a higher laboratory value is not automatically a better outcome. Correction of deficiency and escalation to high concentrations are separate clinical questions.

A responsible orthomolecular approach asks:

  • What problem are we treating?

  • Why is this nutrient likely to help?

  • What dose, form, and duration fit the evidence?

  • What benefit and adverse effects will we measure?

  • When should we adjust or stop?

Reconnect the whole person

I-OM Systems Medicine organizes this work through Divide → Examine → Reconnect → Intervene.

Divide the problem into manageable components: exposures, medicines, diet, nutrient status, sleep, activity, and illness. Examine the evidence for each. Reconnect their interactions. Intervene where there is a defensible target.

A person with weakness might need correction of anemia, medication adjustment, adequate protein, progressive resistance exercise, or treatment of a sleep disorder. Another may have a specific nutrient-responsive condition.

Success should be judged by meaningful improvement: better walking capacity, strength, daily function, symptom burden, or treatment tolerance.

Protect the energy-producing system. Supply what is limiting. Measure whether life improves.

That is a practical foundation for mitochondrial nutrition and healthy longevity.

References

  1. Cheng RZ. Mitochondrial Nutrients and Toxicants in Healthy Longevity—An Evidence Informed Framework for Environmental and Therapeutic Exposures and Contextual Orthomolecular Nutrition. Preprint, 2026. Full manuscript.

  2. Mau T, et al. Lower muscle mitochondrial energetics is associated with greater phenotypic frailty in older women and men. Geroscience. 2024;46:2409–2424. doi:10.1007/s11357-023-01002-1.

  3. Robinson MM, et al. Enhanced protein translation underlies improved metabolic and physical adaptations to different exercise training modes in young and old humans. Cell Metabolism. 2017;25:581–592. doi:10.1016/j.cmet.2017.02.009.

  4. Ryan TE, et al. High-dose atorvastatin therapy progressively decreases skeletal muscle mitochondrial respiratory capacity in humans. JCI Insight. 2024;9. doi:10.1172/jci.insight.174125.

  5. de Jager J, et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency. BMJ. 2010;340. doi:10.1136/bmj.c2181.

  6. Bager P, et al. High-dose oral thiamine versus placebo for chronic fatigue in patients with quiescent inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 2021;53:79–86. doi:10.1111/apt.16166.

  7. Pirinen E, et al. Niacin cures systemic NAD+ deficiency and improves muscle performance in adult-onset mitochondrial myopathy. Cell Metabolism. 2020;31:1078–1090.e5. doi:10.1016/j.cmet.2020.04.008.

  8. Sinha A, et al. Improving the vitamin D status of vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle. Journal of Clinical Endocrinology & Metabolism. 2013;98–E513. doi:10.1210/jc.2012-3592.

  9. Mortensen SA, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: Results from Q-SYMBIO. JACC: Heart Failure. 2014;2:641–649. doi:10.1016/j.jchf.2014.06.008.

  10. Kumar P, et al. Supplementing glycine and N-acetylcysteine in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, physical function, and aging hallmarks. Journals of Gerontology: Series A. 2023;78:75–89. doi:10.1093/gerona/glac135.

  11. Padayatty SJ, et al. Vitamin C pharmacokinetics: Implications for oral and intravenous use. Annals of Internal Medicine. 2004;140:533–537. doi:10.7326/0003-4819-140-7-200404060-00010.

Disclosure: Richard Z. Cheng is the founder of I-OM.ai and developer of the I-OM framework discussed here.

Use of Generative AI: OpenAI ChatGPT and I-OM.ai assisted with literature discovery, manuscript organization, drafting, language editing, and bibliographic checks. I-OM.ai doctrines and principles guided the conceptual framework. The human author retains responsibility for verifying every citation, interpreting evidence, selecting conclusions, disclosing interests, and approving the final text. AI assistance is not evidence of external peer review.

Educational note: This article provides public education and does not replace individualized medical care. Discuss medication changes and therapeutic-dose supplements with a qualified clinician.

About OMNS Global: OMNS Global shares educational articles and discussions on nutrition, orthomolecular medicine, and integrative approaches to health. Continue reading and join the conversation at I-OM Discourse — OMNS Global.